Barclays gives an Equal weight recommendation for Encompass Health Corporation (EHC)


In a filing, Encompass Health Corporation revealed its Chief Medical Officer Charbonneau Elissa Joy unloaded Company’s shares for reported $0.58 million on Aug 17. In the deal valued at $69.58 per share,8,294 shares were sold. As a result of this transaction, Charbonneau Elissa Joy now holds 23,081 shares worth roughly $ 1.62 million.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Then, Tarr Mark J sold 25,330 shares, generating $1,799,950 in total proceeds. Upon selling the shares at $71.06, the President & CEO now owns 497,405 shares.

Before that, COLTHARP DOUGLAS E sold 17,895 shares. Encompass Health Corporation shares valued at $1,087,658 were divested by the EVP & Chief Financial Officer at a price of $60.78 per share. As a result of the transaction, COLTHARP DOUGLAS E now holds 53,097 shares, worth roughly $3.74 million.

Barclays initiated its Encompass Health Corporation [EHC] rating to an Equal weight in a research note published on Tuesday, March 14, 2023; the price target was $57. PT values the company’s stock at a premium of -23.49 to its Tuesday closing price.

Price Performance Review of EHC

On Tuesday, Encompass Health Corporation [NYSE:EHC] saw its stock fall -0.85% to $70.39. On the same session, the stock had its day’s lowest price of $68.35, but rose to a high of $70.80. Over the last five days, the stock has gained 0.57%. Encompass Health Corporation shares have risen nearly 17.69% since the year began. Nevertheless, the stocks have risen 44.57% over the past one year. While a 52-week high of $72.06 was reached on 08/15/23, a 52-week low of $45.11 was recorded on 03/15/23. SMA at 50 days reached $68.51, while 200 days put it at $61.84. A total of 0.67 million shares were traded, compared to the trading of 0.41 million shares in the previous session.

Levels Of Support And Resistance For EHC Stock

The 24-hour chart illustrates a support level at 68.89, which if violated will result in even more drops to 67.40. On the upside, there is a resistance level at 71.34. A further resistance level may holdings at 72.30. The Relative Strength Index (RSI) on the 14-day chart is 54.37, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.69, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.71%. Stochastics %K at 65.90% indicates the stock is a holding.

How much short interest is there in Encompass Health Corporation?

A steep rise in short interest was recorded in Encompass Health Corporation stocks on Aug 14, 2023, growing by 0.36 million shares to a total of 2.73 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 2.37 million shares. There was a rise of 13.19%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 3.11% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.05.

Encompass Health Corporation [EHC] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 9,375,372 shares, or roughly 9.35% of the outstanding EHC shares. In other words, the investor’s shares have fallen by -379,198 from its previous 13-F filing of 9754570.0. Additionally, Wellington Management Co. LLP decreased -2.07% of its stake after which the total value it holdings stand at $593,768,700, while BlackRock Fund Advisors reduced -1.73% of its stake to hold $541.53 million in the firm. Over the last quarter, William Blair Investment Manageme purchased 16,150 shares of Encompass Health Corporation, while SSgA Funds Management, Inc. bought -40,543 shares. At present, Invesco Advisers, Inc. is holding 2,709,528 shares valued at $178.91 million. JPMorgan Investment Management, I owned 2,706,509 shares of the company at the time of its most recent 13F filing, worth $178.71 million.

According to FactSet, Encompass Health Corporation’s share price will average $80.50 in the next year, based on opinions of analysts polled by the firm. This is up nearly 15.51 percent from its previous closing price of $70.99. Analysts expect Encompass Health Corporation stock to reach the higher price of $85.00, while the lowest price estimate is $71.00. However, 11 analysts have rated EHC stock as a Buy in their predictions for 2023.


Please enter your comment!
Please enter your name here